Literature DB >> 9524875

Composite neuropsychological batteries and demographic correction: standardization based on equivalent scores, with a review of published data. The Italian Group for the Neuropsychological Study of Ageing.

E Capitani1, M Laiacona.   

Abstract

Equivalent Scores (ES; Capitani & Laiacona, 1988) is a 5-point scale that offers a solution to the problem of standardizing neuropsychological scores after adjustment for age and education, given that the common z-standardization is not generally applicable in these cases. ES are discussed, and their properties and limits are compared with those of z-standardization. In a battery of ES-standardized tests, the average ES (AES) for the whole battery can provide a measure of the overall cognitive level, free of the influence of age and education. We report empirical data from a battery composed of 10 ES-standardized tests, in order to discuss general properties of ES standardization. The expected mean of the AES is constant, regardless of the number or type of tests included. The standard deviation of the AES, however, is variable: it decreases in proportion to the number of tests, but increases in proportion to their intercorrelation. We provide general indications concerning the normality threshold, which are applicable to all batteries of ES-standardized tests regardless of the number and type.

Entities:  

Mesh:

Year:  1997        PMID: 9524875     DOI: 10.1080/01688639708403761

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  61 in total

1.  A normative study on visual reaction times and two Stroop colour-word tests.

Authors:  R Barbarotto; M Laiacona; R Frosio; M Vecchio; A Farinato; E Capitani
Journal:  Ital J Neurol Sci       Date:  1998-06

2.  Long-lasting hemianopia due to PCA.

Authors:  L Delaj; R D'Alessandro; A Stracciari; C Fonti; L Cretella; R Lodi
Journal:  J Neurol       Date:  2010-03-30       Impact factor: 4.849

3.  Autobiographical memory in amnestic Mild Cognitive Impairment.

Authors:  Ilaria Bizzozero; Federica Lucchelli; Maria Cristina Saetti; Hans Spinnler
Journal:  Neurol Sci       Date:  2012-01-21       Impact factor: 3.307

4.  GEFS+ is not related to the most common mutations of SCN1B, SCN1A and GABRG2 in two Tunisian families.

Authors:  H Mrabet; N Belhedi; S Bouchlaka; A El Gaaied; A Mrabet
Journal:  Neurol Sci       Date:  2008-01-04       Impact factor: 3.307

5.  Twenty years after Spinnler and Tognoni: new instruments in the Italian neuropsychologist's toolbox.

Authors:  Angelo Bianchi; Mirko Dai Prà
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

6.  A novel task assessing intention and emotion attribution: Italian standardization and normative data of the Story-based Empathy Task.

Authors:  Alessandra Dodich; Chiara Cerami; Nicola Canessa; Chiara Crespi; Sandro Iannaccone; Alessandra Marcone; Sabrina Realmuto; Giada Lettieri; Daniela Perani; Stefano F Cappa
Journal:  Neurol Sci       Date:  2015-06-14       Impact factor: 3.307

7.  How to assess abstract conceptual knowledge: construction, standardization and validation of a new battery of semantic memory tests.

Authors:  Pasquale Anthony Della Rosa; Eleonora Catricalà; Silvia De Battisti; David Vinson; Gabriela Vigliocco; Stefano F Cappa
Journal:  Funct Neurol       Date:  2014 Jan-Mar

8.  Normative data for distal line bisection and baking tray task.

Authors:  Alessio Facchin; Nicoletta Beschin; Alessia Pisano; Cristina Reverberi
Journal:  Neurol Sci       Date:  2016-06-03       Impact factor: 3.307

9.  VATA-m: Visual-Analogue Test assessing Anosognosia for motor impairment.

Authors:  S Della Sala; G Cocchini; N Beschin; A Cameron
Journal:  Clin Neuropsychol       Date:  2009-02-11       Impact factor: 3.535

10.  Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment.

Authors:  Emilia Salvadori; Marco Pasi; Anna Poggesi; Guido Chiti; Domenico Inzitari; Leonardo Pantoni
Journal:  J Neurol       Date:  2013-05-29       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.